All Industries

Top Biotech Companies

8,620 Biotech companies, sorted by total funding raised.

Elevate Bio

ElevateBio is a technology-driven company that partners with innovators to develop transformative...

Waltham, United States201–500Biotech, Healthcare
Series DTotal funding$1.2BMay 2023
Neuralink

Neuralink develops investigational implantable brain-computer interfaces that help people with pa...

Fremont, United States201–500Biotech, Healthcare
Series ETotal funding$1.2BJun 2025
BioNTechIPO

BioNTech develops immunotherapies and vaccines for cancer, infectious diseases, and other serious...

Mainz, Germany5001–10000Biotech, Healthcare
Series BTotal funding$1.2BJul 2019
PacBioIPO

Developer and manufacturer of high-accuracy long-read DNA sequencing systems and consumables for ...

USA, United States501–1000Biotech, Genomics
ConvertibleTotal funding$1.2BFeb 2021
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
argenx SEIPO

Global biopharmaceutical company developing antibody-based therapies for severe autoimmune diseas...

Amsterdam, Netherlands501–1000Biotech, Healthcare
Growth EquityTotal funding$1.1BJul 2023
Enveda

Enveda reads and translates nature’s hidden chemistry to accelerate the discovery of better medic...

Boulder, United States201–500Biotech, Artificial Intelligence
Series ETotal funding$1.1BSep 2026
Ultima Genomics

Ultima Genomics develops high-throughput DNA sequencing platforms that use open-wafer technology ...

Fremont, United States201–500Artificial Intelligence, Healthcare
Series ETotal funding$1.1BJun 2022
Eikon TherapeuticsIPO

Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...

Hayward, United States201–500Artificial Intelligence, Biotech
Series DTotal funding$1.1BFeb 2025
Seattle GeneticsAcquired

Biotechnology company focused on developing and commercializing innovative, empowered monoclonal ...

Bothell, United States1001–5000Biotech
Corporate RoundTotal funding$1.0BSep 2020
GeneDxIPO

GeneDx provides genetic testing, clinical interpretation, and genomic insights that help healthca...

Stamford, United States501–1000Biotech, Healthcare
Corporate RoundTotal funding$1.0BJan 2022
Alnylam PharmaceuticalsIPO

Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Cambridge, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$1.0BApr 2020
KaileraIPO

Kailera develops therapies for obesity built on GLP-1-based mechanisms, advancing four clinical-s...

Waltham, United States51–200Biotech, Healthcare
Series BTotal funding$1.0BOct 2025
Xaira Therapeutics

Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intellig...

South San Francisco, United States51–200Artificial Intelligence, Biotech
Series ATotal funding$1.0BApr 2024
COMPASS PathwaysIPO

COMPASS Pathways is dedicated to accelerating patient access to evidence-based innovation in ment...

London, United Kingdom51–200Healthcare, Mental Health
Venture RoundTotal funding$997.0MFeb 2026
TempusIPO

Tempus is a technology company focused on collecting and analyzing large volumes of molecular and...

Chicago, United States1001–5000Artificial Intelligence, Biotech
Series G+Total funding$960.0MOct 2021
ArsenalBio

Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...

San Francisco, United States201–500Biotech, Life Sciences
Series CTotal funding$955.0MSep 2024
Cellares

Cellares develops and operates automated smart factories that manufacture cell therapies for biot...

South San Francisco, United States51–200Biotech, Healthcare
Series DTotal funding$939.0MJun 2026
ZymergenClosed

Zymergen was a biomanufacturing company using AI and machine learning to engineer microbes for pr...

Emeryville, United States501–1000Advanced Materials, Artificial Intelligence
Series DTotal funding$928.1MSep 2020
Apeel Sciences

Apeel Sciences develops plant-based edible coatings that extend the shelf life of fresh produce, ...

GOLETA, United States201–500Agtech, Biotech
Series FTotal funding$912.9MJul 2025
Gossamer BioIPO

Gossamer Bio develops seralutinib, an investigational inhaled therapy for pulmonary arterial hype...

San Diego, United States51–200Biotech, Healthcare
Private EquityTotal funding$912.0MAug 2026
Celularity

Celularity is a biotechnology company developing off-the-shelf placental-derived allogeneic cell ...

Florham Park, United States51–200Biotech, Healthcare
Extension RoundTotal funding$895.0MJan 2021
Lyell ImmunopharmaIPO

Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...

South San Francisco, United States201–500Biotech, Healthcare
Venture RoundTotal funding$884.0MJul 2025
Candid TherapeuticsClosed

Clinical-stage biotechnology company developing T-cell engager therapeutics for autoimmune and in...

San Diego, United States11–50Biotech, Therapeutics
Venture RoundTotal funding$875.0MMar 2026
Spiber

Spiber develops Brewed Protein materials, using microbial fermentation to create plant-based fibe...

Tokyo, Japan201–500Biotech, Manufacturing
Venture RoundTotal funding$872.9MDec 2024